George Tidmarsh
About George Tidmarsh
George Tidmarsh, M.D., Ph.D., is an accomplished biotechnology professional with over 30 years of experience, known for his significant contributions to the development of several FDA-approved drugs, including treatments for shock, severe malaria, and rheumatoid arthritis.
George Tidmarsh Education and Training
George Tidmarsh received both his M.D. and Ph.D. from Stanford University. He completed his fellowship training in Pediatric Oncology and Neonatology at the same institution. Since 2018, he has been serving as Adjunct Faculty of Pediatrics and Neonatology at Stanford University. Prior to this role, George served as clinical faculty at Stanford for several years following his fellowship.
George Tidmarsh Professional Experience
George Tidmarsh has over 30 years of experience in the biotechnology industry. He has held several leading positions, most notably as President, Chief Executive Officer, Secretary, and Director of La Jolla Pharmaceutical Company from January 2012 until November 2019. Previously, he served as the Chief Executive Officer of Horizon Pharma, Inc., a company he founded in 2005. George has also founded Threshold Pharmaceuticals, Inc., and held senior positions at Coulter Pharmaceutical, Inc. and SEQUUS Pharmaceuticals, Inc.
George Tidmarsh FDA-Approved Drug Developments
Throughout his career, George Tidmarsh has led the clinical development of seven FDA-approved drugs. Noteworthy among these is his work on Duexis, approved for the treatment of rheumatoid arthritis, and artesunate, approved for the treatment of severe malaria. Additionally, he played a pivotal role in the development of BEXXAR and Doxil, both FDA-approved anti-cancer agents.
George Tidmarsh Contributions to Medical Research
George Tidmarsh has contributed significantly to medical research, particularly in the field of biotechnology. He helped discover the use of angiotensin II for the treatment of shock. His expertise in drug development and clinical trials has led to several significant advancements in medical treatments, benefiting countless patients worldwide.